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Abstract
Background: 2’-5’ oligoadenylate synthetases (OAS) are interferon inducible enzymes that polymerizes ATP
to 2’-5’-linked oligomers of adenylate (2-5As). As part of the innate immune response, these enzymes are
activated by viral double stranded RNA or mRNAs with significant double stranded structure. The 2-5As in
turn activate RNaseL that degrade single stranded RNAs. Three distinct forms of OAS exist in human cells
(OAS1, 2 and 3) with each form having multiple spliced variants. The OAS enzymes and their spliced variants
have different enzyme activities. OAS enzymes also play a significant role in regulating multiple cellular processes such
as proliferation and apoptosis. Moreover, Single nucleotide polymorphisms that alter OAS activity are also associated
with viral infection, diabetes and cancer. Thus detection of OAS enzyme activity with a simple spectrophotometric
method in cells will be important in clinical research.
Results: Here we propose a modified coupled spectrophotometric assay to detect 2-5 oligoadenylate synthetase (OAS)
enzyme activity in prostate cell lines as a model system. The OAS enzyme from prostate cancer cell lysates was purified
using Polyinosinic: polycytidylic acid (poly I:C) bound activated sepharose beads. The activated OAS enzyme
eluted from Sepharose beads showed expression of p46 isoform of OAS1, generally considered the most
abundant OAS isoform in elutes from DU14 cell line but not in other prostate cell line. In this assay the
phosphates generated by the OAS enzymatic reaction is coupled with conversion of the substrate 2-amino-6-
mercapto-7-methylpurine ribonucleoside (methylthioguanosine, a guanosine analogue; MESG) to a purine base
product, 2-amino-6-mercapto-7-methylpurine and ribose1-phosphate via a catalyst purine nucleoside phosphorylase
(phosphorylase) using a commercially available pyrophosphate kit. The absorbance of the purine base product is
measured at 360 nm. The higher levels of phosphates detected in DU145 cell line indicates more activity of OAS in
this prostate cancer cell line.
Conclusion: The modified simple method detected OAS enzyme activity with sensitivity and specificity, which could
help in detection of OAS enzymes avoiding the laborious and radioactive methods.
Keywords: 2-5 oligoadenylate synthetase, Pyrophosphate assay, Prostate cancer
Background
The interferon inducible anti-viral 2-5 oligoadenylate
synthetase (OAS) enzyme is part of the cellular innate
immune response [1–3]. There are eight to ten OAS
isoforms due to alternative splicing and gene duplica-
tions [4, 5]. In humans, the OAS gene family is composed
of four genes on locus 12q24.1-q24.2: hOAS1, hOAS2,
hOAS3 and hOASL [6, 7]. A pathogen-associated molecu-
lar pattern (PAMPs) such as dsRNA or mRNA with
significant double stranded structures stimulates OAS to
catalyze the polymerization of ATP to form 2’-5’-linked
oligomers of adenylate (2-5As) [4, 8]. The subsequent
elongation reaction is (n + 1) ATP→ Ppp5’A(2’p5’A)n +
nPPi [9]. 2-5A functions through its receptor, the 2-5A-
dependent ribonuclease (RNaseL), a ubiquitous 83-kDa
protein that dimerizes into its catalytically active form
upon binding 2-5A [4, 10, 11]. The activated RNaseL
cleaves the single stranded RNA with UU or UA
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dinucleotide at the 3’ end [4, 8, 12, 13]. Thus acti-
vated OAS-RNaseL system degrades viral and cellu-
lar RNA and subsequently inhibits protein synthesis
[14]. Earlier studies also showed that OAS-RNase L
system triggers apoptosis via mitochondrial pathway
[15, 16]. It is also known that OAS silencing attenu-
ates interferon induced anti-proliferative and antiviral sig-
naling and stimulates anchorage independent cell growth
[8]. The exogenous recombinant porcine OAS1 exhibits
broad-spectrum antiviral activity through the activation of
the IFN system that is independent of RNaseL [17]. Thus
OAS1 dependent polymerization of ATP regulates mul-
tiple cellular functions that are dependent or independent
of RNaseL.
OAS1 gene single nucleotide polymorphism (SNP) is
associated with wide variety of health related disorders
such as hepatitis C infection [18, 19], West Nile virus
infection [20], SARS [21] and Type1 diabetes [22]. The
haplotype variations in OAS1 gene also confer susceptibil-
ity to multiple sclerosis [23]. A recent study also showed a
non-synonymous SNP rs2660 (G-A) is associated with ra-
cial disparities in prostate cancer [24]. It is being demon-
strated that OAS1 gene alternative splicing is in part due
to SNP at the splice acceptor site (rs10774671) generates
p46 and p48 isoforms with different ATP polymerization
activity [25]. Collectively, SNPs in OAS gene results in
variation in activity of the enzyme which could be associ-
ated increased susceptibility for several disorders listed
above. Thus, development of a simple and accurate assay
to detect the activity of OAS1 enzyme is of significant
clinical interest.
Earlier, OAS activity was analyzed by determining the
inhibitory effect of 2-5A on protein translation [26],
detection of 2-5A polymers in the presence of radio-
active ATP [27–29] and/or cleavage of radioactive 2-5A
with alkaline phosphatase to cleave the triphosphate
group at the end of the core nucleotide. Later, Justesen
et al. developed a method to separate radioactive ATP
and 2-5A by PEI-cellulose thin layer chromatography
without the use of alkaline phosphatase [30]. The method
was subsequently improved to measure inorganic pyro-
phosphate (PPi) through a spectrophotometric assay [9].
This method is a coupled enzymatic reaction utilizing
three enzymes UDP-Glc pyrophosphorylase, phosphoglu-
comutase and glucose-6-phosphate dehydrogenase. The
coupled reaction results in formation of NADPH which is
measured by fluorescence spectroscopy [9]. The use of
extensive OAS1 chromatographic purification steps, ex-
pensive reagents, and series of reactions utilized in this
methodology to detect OAS enzyme has made it more
cumbersome, laborious and expensive.
The detection of inorganic phosphate released from bio-
logical systems, such as GTPases and ATPases has been
developed earlier [31]. The phosphate generated during
the enzymatic reaction converts the substrate 2-amino-6-
mercapto-7-methylpurine ribonucleoside (methylthio-
guanosine, a guanosine analogue; MESG) to a purine
base product, 2-amino-6-mercapto-7-methylpurine and
ribose1-phosphate via a catalyst purine nucleoside phos-
phorylase. This conversion causes a shift in absorbance
from 330 nm of substrate (MESG) to 360 nm of purine
base product (2-amino-6mercapto-7-methylpurine) [31].
Further this method was modified to detect pyrophos-
phates generated in several biochemical reactions by con-
verting the pyrophosphates to inorganic phosphates by a
phosphatase. Thus the reaction producing pyrophosphate
can be coupled to inorganic phosphate detection [31].
This modified method of detecting pyrophosphate has
been known to measure activity of acetyl CoA synthetase
and amino-acyl-tRNA synthetase activity which are also
involved in pyrophosphate generation [32, 33]. The modi-
fied pyrophosphate detection method is also employed in
hydroxamate-MESG assay which measures the activity of
adenylating enzyme via measurement of pyrophosphate
generated from ATP during the activation of carboxylic
acid to form acyl-adenylate intermediate. The coupled
hydroxamate assay characterizes the adenylate enzyme
that do not undergo rapid ATP –PPi exchange during the
acylation of the protein substrate like hydroxamate [34].
In this study, the OAS enzyme from prostate cell
lysates was first affinity purified and activated with the
use of sepharose beads conjugated with Poly I:C (Polyi-
nosinic: polycytidylic acid). The purified enzyme was
eluted with elution buffer resulting in the generation of in-
organic pyrophosphate. We exploited the polymerization
reaction which converts ATP in the elution buffer to 2-5A
and pyrophosphates by poly I:C affinity purified OAS and
coupled the OAS enzyme reaction generating pyrophos-
phate with the modified method of detecting pyrophos-
phates based on conversion of MESG substrate to purine
based product 2-amino-6-mercapto-7-methylpurine by
phosphates. This method for detecting OAS enzyme
is less laborious, nonhazardous and cost effective over




All the cell lines were purchased from ATCC. The
normal prostate epithelial cell line RWPE1 (ATCC) was
cultured in K-SFM (keratinocyte serum free medium)
supplemented with BPE (Bovine pituitary extract) and
EGF (Epidermal growth factor) as per the supplier’s
recommendation. The 293T were cultured in high glu-
cose DMEM media. The prostate cancer cell lines LNCaP
were culture in RPMI, DU145 in F12 medium. The cells
were incubated at 37 °C and 5 % CO2 under sterile
conditions.
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Reagents
Sodium periodate (NaIO4), Sodium azide, Sepharose and
Cyanoborohydride coupling buffer were obtained from
Sigma-Aldrich. Poly I:C and EnzChek pyrophosphate Kit
were purchased from Invitrogen, Cell lysis buffer M-PER
were obtained from Pierce.
Affinity Purification for OAS Enzyme
Sepharose beads (Sigma) were activated by 10 mM so-
dium periodate solution in 1 M sodium acetate (pH 5.5).
One bed volume of sepharose beads were mixed with
activation solution at room temperature for 30 min
followed by washing twice with distilled water.
Poly I:C Coupling to Activated Sepharose Beads
The poly I:C coupling buffer was prepared by dissolving
2 mg of Poly I:C in 1 ml of cyanoborohydride coupling
buffer. One ml bed volume of periodate activated seph-
arose beads were washed twice and mixed with equal
volume of poly I:C coupling buffer at room temperature
(RT) for 3 h, followed by gentle mixing at 4 °C for 20 h.
The beads were then centrifuged at 500 X g for 2 min
and washed with 4 ml of coupling buffer. After washing,
the residual reactive groups were blocked by incubating
the beads with coupling buffer containing 0.5 M Tris-
HCl (pH 7.4) for 60 min at RT with gentle agitation.
Finally, the beads were washed three times with 10 ml
PBS and then stored at 4 °C in PBS (pH-7.4) containing
0.02 % sodium azide until further use (Fig. 1a).
Purification of OAS Enzyme with Poly I:C Sepharose
Beads
Cells were lysed with cell lysis buffer M-PER. Total
cellular protein was quantified with Bradford assay
(Bio-Rad). Proteins (20 μg) diluted with dH2O in total
volume of 20 μl were mixed with equal volume of
Poly I:C conjugated Sepharose beads (Fig. 1b). Poly
I:C bound Sepharose beads stored in sodium azide
were prewashed with PBS before use. The cell lysate
and Sepharose beads mixture was incubated for 30 min at
30 °C with gentle agitation for adsorption and activation
of OAS enzyme on Poly I:C conjugated and activated
Sepharose beads. Following incubation, the beads were
further washed several times with PBS. Finally, OAS
Fig. 1 Method to measure OAS enzyme activity. Schematics of a Activation and Conjugation of Poly I:C to sepharose beads, b Purification of OAS
enzyme and c OAS enzymatic reaction coupled to pyrophosphate reaction
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enzyme bound to poly I:C was eluted by incubating
Sepharose beads with 25 μl of elution buffer [20 mM of
magnesium acetate, 1.5 mM of ATP, 1 mM DTT, 25 mM
HEPES (pH 7.5), 50 μg/ml of poly I:C] for 16 h at 30 °C
with gentle mixing. The beads were then centrifuged at
500 x g for 2 min and the supernatant containing the
elution buffer and the active enzyme product was sepa-
rated and store at −20 °C. The elution buffer contains Poly
I:C which can elute OAS from Sepharose beads by com-
petitive affinity binding.
Pyrophosphate Assay
Pyrophosphate (PPi) generated in a polymerization re-
action of ATP by OAS was detected using an EnzChek
pyrophosphate kit. Assays were performed as per the
manufacturer’s instructions with some modifications.
Briefly all the assay components: 20x reaction mixture,
MESG substrate, OAS enzyme/inorganic phosphate for
standard curve, purine nucleoside phosphorylase (PNP),
and inorganic pyrophosphatase were mixed in a total
reaction volume of 100 μl. The reaction mixture was
incubated at room temperature for 15–20 min. The
absorbance of MESG was first measured at 330 nm. After
addition of the enzyme, the conversion of MESG to the
product 2-amino-6-mercapto-7-methylpurine by phos-
phate (Pi) was measured at 360 nm. A standard curve with
increasing concentration of inorganic phosphates was
expressed in terms of increasing absorbance of the prod-
uct at 360 nm. A wavelength scan for shifts in absorbance
as the reaction proceeded from approximately 330 nm to
360 nm in the presence of Sepharose conjugated Poly I:C
alone was measured as a baseline.
Western Blotting
The purified cell lysates obtained by Poly I:C conjugated
activated Sepharose beads was investigated for the
expression of p46 isoform of OAS1. Briefly, 20 μg of
purified and crude lysates from 293T, DU145, LNCaP
and RWPE1 were loaded on 10 % SDS-PAGE gel and
transferred on nitrocellulose paper. The p46 OAS1 iso-
form was detected by goat primary antibody against p46
(OAS1 (A-17), goat polyclonal, Santa Cruz Biotechnology)
using standard western blot protocol. The blots were
analyzed using Fujifilm image analyzer (LUMINESCENT
IMAGE ANALYZER LAS-300). GAPDH was used as a
loading control. DU145 cell lysates purified using inactive
Sepharose beads with no Poly I:C conjugated were used as
a negative control. The Poly I:C unbound fraction of cell
lysates obtained were also tested for detecting the fraction
of P46 active isoform of OAS.
Statistical Analysis
The Statistical significance was calculated by one tailed
unpaired t-test. The OAS activity in cell lines was
compared to the activity in lysates from control DU145
cells which was purified by un-activated Sepharose beads
without Poly I:C. The assay was performed thrice in
triplicates. The P value is represented as *** for <0.005
and as * for value < 0.05 is shown.
Result and Discussion
Interferon inducible and dsRNA activated 2-5 OAS is
a critical component in the enzymatic reaction to
form 2-5A polymer which is an activator of RNaseL.
Together, the 2-5A/RNaseL system forms a vital part
of innate immune system [4, 10, 11]. The activated
RNaseL degrades the viral RNA and provides defense
against infected viruses [14]. The variation in enzyme
activity is attributed to non-synonymous single nucleotide
polymorphism at the splice acceptor site in the last exon
for at least OAS1. This variant of OAS1 enzyme is associ-
ated with increased viral infection due to lack of OAS
enzyme function [25].
Here, we developed a simple method of detecting
OAS by coupling pyrophosphates generated during the
polymerization of ATP to form 2-5A in presence of the
enzyme OAS to the conversion of MESG substrate to
purine based product with absorbance peak at 360 nm
by using a commercially available kit. The enzyme in
the cell lysates was activated and purified using NaIO4
activated and poly I:C conjugated sepharose beads
(Fig. 1). The purified enzyme polymerizes ATP and re-
leases pyrophosphates. Further, pyrophosphates are
converted to phosphate in the presence of inorganic
phosphatase to the reaction. In the presence of ribonu-
cleoside phosphorylase (PNP), phosphates react with
substrate MESG and converts it to 2-amino-6-mercapto-
7-methylpurine and ribose 1- phosphate (Fig. 1). Earlier,
this method has been utilized to measure phosphates
released by enzymes like actin activated myosin ATPase
[31] and phosphorylase kinase [35] and AcsD, an
acyladenylate-forming enzyme from Pectobacterium
chrysanthemi [36]. This method has advantage over
several earlier less sensitive assay involving multistep
reactions [37].
Detection of OAS1 p46 Isoform in Poly I:C Affinity Beads
Purified Lysates
As described earlier, we purified OAS from the cell
lysates using affinity capture technique (see schematic in
Fig. 1). The Poly I:C conjugated and activated sepharose
beads to purify OAS enzymes from cell lysates is well
established and described earlier [38]. The bound en-
zyme was eluted and was analyzed for the expression of
p46 isoform of OAS1 before testing the purified lysates
to detect OAS enzyme activity. The OAS1 (p46) isoform
protein expression was detected in crude cell lysates
from DU145 cell lines but was absent or non-detectable
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in 293T, LNCaP and RWPE1 cell lines. The 293T cell
line was used as a negative control as it lacks the active
form of OAS1 (Fig. 2a). Figure 2b shows the OAS1 (p46)
isoform expression in the cell lysates purified by Poly I:C
conjugated Sepharose beads. OAS1 (p46) was detected
in the poly I:C sepharose affinity purified lysates from
DU145 cells but not in the purified lysates from other
prostate cell lines and 293T cells. Thus the presence of
OAS1 in purified lysates of DU145 suggested that the
poly I:C conjugated sepharose affinity purification sys-
tem is functional and results in the enrichment of
OAS enzyme. The absence of detectable OAS enzyme
from the DU145 cell lysate purified with inactivated
Sepharose beads with no bound poly I:C used as a
negative control further supports the specificity of the
affinity purification system. Furthermore, no GAPDH
expression was observed in the purified fraction sug-
gesting the poly I:C conjugated sepharose beads spe-
cifically captured only OAS (Fig. 2b). The first wash
flow through, collected after binding of OAS enzyme
to poly I:C-sepharose beads resulted in undetectable
p46 OAS1 enzyme suggesting that the affinity column
captured essentially all the enzyme present in the cell
lysate (Fig. 2b). These purified fractions were used for
detecting OAS enzyme assay by simple and rapid
pyrophosphate assay.
Measurement of Pyrophosphate
The pyrophosphate assay uses MESG substrate which
reacts with phosphate in presence of enzyme purine ribo-
nucleoside phosphorylase (PNP). The resulting product
has an absorbance at 360 nm. A standard curve was
constructed to detect the change in absorbance with in-
creasing concentration of pyrophosphate. A gradual de-
crease in MESG absorbance with increasing concentration
of pyrophosphate at 330 nm was observed after addition
of enzyme PNP and inorganic phosphatase (Fig. 3a).
Correspondingly, with the increasing concentration of the
pyrophosphate, an increase in the absorbance of the prod-
uct 2-amino-6-mercapto-7-methylpurine was observed at
Fig. 2 OAS1 protein expression in crude and purified lysates of
prostate cancer cell line. OAS1 p46 isoform expression in lysates
from 293T, RwPE1, DU145 and LNCaP cell line. a OAS 1 expression
in 20 μg crude lysates (upper panel) and GAPDH (lower panel) was
used as a loading control. b OAS 1 expression in lysates purified
from 20 μg of crude lysates with activated poly I:C bound sepharose
beads (upper panel), GAPDH (middle panel) was used as a loading
control and elute-1 collected during washing to remove the unbound
OAS enzyme and OAS free cell lysates. DU145 lysates purified with
unactivated sepharose beads with no poly I:C bound to it was used
as a negative control
Fig. 3 Standard curve for measurements of pyrophosphates.
a Absorbance of MESG substrate at 330 nm with increasing
concentration of pyrophosphates (10–60 μM) with or without
PNP and inorganic phosphatase. b Absorbance of purine based
product, 2-amino-6-mercapto-7-methylpurine at 360 nm with
increasing concentration of pyrophosphates (10–60 μM) with
or without PNP and inorganic phosphatase
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360 nm (Fig. 3b). The activity of OAS in the Poly I:C con-
jugated affinity beads purified cell lysate in terms of the
pyrophosphate generated during enzymatic reaction can
be detected by measuring increase in absorbance of the
product or decrease in absorbance of the substrate. The
amount of pyrophosphate generated can then be deter-
mined from the standard curve (Fig. 3a and b).
Measurement of OAS Enzyme Activity in Purified Prostate
Cell Lysates
The purified lysates tested for expression of p46 iso-
form of OAS1 (Fig. 2) were analyzed for OAS enzyme
activity. The enzyme activity measured in purified pros-
tate cell lysates and the negative control 293T cells
which lack endogenous OAS1 by pyrophosphate assay
kit. The enzymatic conversion of 2-amino-6-mercapto-
7-methylpurine ribonucleoside (MESG) substrate to 2-
amino-6-mercapto-7-methylpurine is directly proportional
to the amount of inorganic phosphate produced by the
OAS enzyme. There is a significant increase in absorbance
of product 2-amino-6-mercapto-7-methylpurine at 360 nm
in DU145 cell lines showing high OAS enzyme activity in
this cell lines as compared to the other two prostate cell
lines which did not show any enzyme activity (Fig. 4).
OAS enzyme activity was not observed in negative control
293T purified cell lysate and the DU145 cell lysate passed
through sepharose beads not activated or conjugated to
Poly I:C. These results demonstrated a consistency be-
tween the expression and activity of OAS1 enzyme (p46)
in purified lysates from DU145 cell lines as compared to
other prostate cell lines (Figs. 2 and 4).
Fig. 4 Enzyme activity in prostate cancer cell line. OAS enzyme
assay measurement with pyrophosphate assay in lysates purified
from 293T, RwPE1, LNCaP, DU145 and control which is lysate from
DU145 cell purified with unactivated sepharose beads with no poly
I:C. Shift in absorbance at 360 nm after completion of reaction post
addition of PNP and inorganic phosphatase. Assay was done thrice
in triplicates. Statistical significance is shown as *** for p < 0.005 and
* for p < 0.05
Fig. 5 Wavelength Scan (300 nm–390 nm) for purified lysates from DU145 cell lines. A) MESG substrate only, B) MESG + OAS + PNP and
C) MESG + OAS + PNP + inorganic phosphatase
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Wavelength Scans for Purified OAS Enzyme from DU145
Cell Lysate
As described in methods, the MESG substrate shows
peak absorbance at 330 nm. As the reaction proceeds,
the product formed has an absorbance shift that peaks
at 360 nm. The data shown in Fig. 5 shows the expected
wavelength shift from 330 nm to 360 nm for the enzym-
atic reaction on purified cell lysates from DU145 cells.
These results indicated that the Poly I:C bound sephar-
ose beads affinity purifies and activates OAS enzyme in
DU145 cell lysates. The eluted purified lysate rich in
OAS enzyme reacts with ATP in the elution buffer and
polymerizes it to generate 2-5A and pyrophosphates.
The pyrophosphate is further converted in to single
phosphate molecules with the help of the enzyme pyro-
phosphatase. The phosphates react with the substrate
MESG with peak absorbance at 330 nm and convert it
to the product with peak absorbance at 360 nm, thus
creating the shift in the absorbance peak and suggesting
higher activity in purified DU145 cell lysates.
Conclusion
This proposed method simplifies the detection/purifica-
tion of OAS activity in prostate cancer cell line. The
spectrophotometric method is a simple two step reaction
based on measurement of pyrophosphates generated
during ATP polymerization reaction in the presence of
active OAS enzyme. The pyrophosphate is converted in
to phosphate by inorganic phosphatase enzyme and the
reaction of phosphates with its substrate MESG results
in formation of purine based product causing shift in the
absorbance from 330 nm to 360 nm. This technique has
advantage over hazardous radio-labelling and time con-
suming methods with more than 4–5 step reactions to
measure active OAS enzyme in prostate cells. The method
can be applied to detect OAS activity from any cell/tissue
with appropriate modification.
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